Status:

UNKNOWN

Effects of Laser Therapy and Exercise in Participants With Chronic Low Back Pain

Lead Sponsor:

Federal University of the Valleys of Jequitinhonha and Mucuri

Conditions:

Low Back Pain (LBP)

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The objective of this clinical trial is to evaluate the additional effects of Laser Therapy in participants with chronic non-specific low back pain in the short and long term.

Detailed Description

The objective of this clinical trial is to evaluate the additional effects of Photobiomodulation Therapy in participants with chronic non-specifc low back pain in the short and long term.

Eligibility Criteria

Inclusion

  • Patients with non-specific chronic LBP, defined as pain or discomfort between the costal margins and inferior gluteal folds with or without referred pain to the lower limbs;
  • Persistent LBP for at least 3 months;
  • Low back pain of intensity reported 3 or higher by the Visual Analogue Scale (VAS), at least once in the previous 7 days;
  • Aged between 18 and 65 years;
  • Both genders.

Exclusion

  • Patients with severe skin diseases (eg, skin cancer, erysipelas, severe eczema, severe dermatitis, severe psoriasis and severe hives lupus);
  • Participants with known or suspected serious spinal pathology (e.g., fractures, tumors, inflammatory, rheumatologic disorders, or infective diseases of the spine);
  • Nerve root compromise;
  • History of previous spinal surgery (even in a segment other than the lumbar spine) or scheduled surgery;
  • Pain due to or associated with pregnancy or structural deformity (for example, scoliosis);
  • Pregnancy;
  • Comorbid health conditions that could prevent active participation in the exercise programs such as high blood pressure, pregnancy, or cardio-respiratory illnesses;
  • Having answered "yes" to any of the questions in the Physical Activity Readiness Questionnaire (PAR-Q);
  • Be treated with PBMT;
  • Being under physiotherapeutic treatment or perform physical exercise;
  • Who are using NSAID or start it during the trial;
  • Who have inability to tolerate the proposed experimental procedures (such as tests of mobility and strength of the lumbar muscles).

Key Trial Info

Start Date :

June 2 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT04287725

Start Date

June 2 2021

End Date

December 31 2022

Last Update

March 8 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.